Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 2363 Records) |
| Query Trace: Disease and Egfr[original query] |
|---|
| Comparison of treatment regimens for unresectable stage III epidermal growth factor receptor (EGFR) mutant non-small cell lung cancer. Chinese medical journal 2024 12 . Xin Dai, Qian Xu, Lei Sheng, Xue Zhang, Miao Huang, Song Li, Kai Huang, Jiahui Chu, Jian Wang, Jisheng Li, Yanguo Liu, Jianyuan Zhou, Shulun Nie, Lian L |
| Clinical value of epidermal growth factor receptor mutation testing in peripheral blood of patients with non-small cell lung cancer. Pakistan journal of medical sciences 2024 12 40 (11): 2626-2630. Xiaomeng Zheng, Chengbi Tong, Xiaodong Li, Yanan Meng, Xiaodan L |
| EGFR Exon 19 Insertions: Do Patients Respond to Tyrosine Kinase Inhibitor Treatment? Anticancer research 2024 12 45 (1): 335-340. Giuseppina Improta, Giulia Vita, Alfredo Tartarone, Giovanni Calice, Ludmila Carmen Omer, Angela Zu |
| Prognostic Value of KRAS/TP53 Status for Overall Survival in First-Line Monoimmunotherapy and Chemoimmunotherapy Treated Patients With Nonsquamous NSCLC in the Netherlands: A Brief Report. JTO clinical and research reports 2024 12 5 (12): 100745. Vincent D de Jager, Léon C van Kempen, Betzabel N Cajiao Garcia, T Jeroen N Hiltermann, Anthonie J van der Wekken, Ed Schuuring, Stefan M Wille |
| Neoadjuvant and adjuvant osimertinib in stage IA-IIIA, EGFR-mutant non-small cell lung cancer (NORA). Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2024 12 . Jii Bum Lee, Su-Jin Choi, Hyo Sup Shim, Byung Jo Park, Chang Young Lee, Sumedha Sudhaman, Sharlene Velichko, Min Hee Hong, Byoung Chul Cho, Sun Min L |
| Limited Efficacy of Anti-EGFR Monoclonal Antibodies in Colorectal Cancer Patients with Rare RAS Variants: Analysis of the C-CAT Database. Current issues in molecular biology 2024 12 46 (12): 14476-14486. Shuhei Suzuki, Yosuke Saito, Koki Saito, Yuta Yamada, Koshi Takahashi, Ryosuke Kumanishi, Tadahisa Fukui, Takashi Yoshio |
| The prevalence and clinical significance of EGFR mutations in non-small cell lung cancer patients in Egypt: a screening study. Journal of the Egyptian National Cancer Institute 2024 12 36 (1): 39. Asmaa A Helal, Ibrahim H Kamal, Ahmed Osman, Magdy Youssef, Adel K Ibrah |
| Integrated use of Autosomal Dominant Polycystic Kidney Disease Prediction Tools and Risk Prognostication. Clinical journal of the American Society of Nephrology : CJASN 2024 12 . Constantin A Wolff, Valeria Aiello, Elhussein A E Elhassan, Carlotta Cristalli, Sarah Lerario, Alexandro Paccapelo, Francesca Ciurli, Francesca Montanari, Amalia Conti, Katherine Benson, Marco Seri, Carolin B Brigl, Julia S Münster, Nicola Sciascia, Sebastian Kursch, Jonathan de Fallois, Gaetano La Manna, Kai-Uwe Eckardt, Nina Rank, Bernt Popp, Ria Schönauer, Peter J Conlon, Irene Capelli, Jan Halbritt |
| Observational study of the efficacy and safety of first-line osimertinib and later treatments for uncommon epidermal growth factor receptor-activating mutation-positive advanced non-small cell lung cancer. Japanese journal of clinical oncology 2024 12 . Tsuyoshi Hirata, Kageaki Watanabe, Yukio Hosomi, Kiyotaka Yoh, Kazuhiro Usui, Kazuma Kishi, Go Naka, Shu Tamano, Kohei Uemura, Hideo Kunit |
| Clinical outcomes of patients with EGFR-mutated NSCLC developing interstitial lung disease during first-line osimertinib therapy: a sub-analysis of the Reiwa study. Japanese journal of clinical oncology 2024 12 . Takayuki Kobayashi, Kageaki Watanabe, Yukio Hosomi, Kiyotaka Yoh, Kazuhiro Usui, Kazuma Kishi, Go Naka, Shu Tamano, Kohei Uemura, Hideo Kunit |
| Metabolomics profiling in multi-ancestral individuals with type 2 diabetes in Singapore identified metabolites associated with renal function decline. Diabetologia 2024 12 . Yuqing Chen, Federico Torta, Hiromi W L Koh, Peter I Benke, Resham L Gurung, Jian-Jun Liu, Keven Ang, Yi-Ming Shao, Gek Cher Chan, Jason Chon-Jun Choo, Jianhong Ching, Jean-Paul Kovalik, Tosha Kalhan, Rajkumar Dorajoo, Chiea Chuen Khor, Yun Li, Wern Ee Tang, Darren E J Seah, Charumathi Sabanayagam, Radoslaw M Sobota, Kavita Venkataraman, Thomas Coffman, Markus R Wenk, Xueling Sim, Su-Chi Lim, E Shyong T |
| Urinary Dickkopf-3 as a Potential Marker for Estimated Glomerular Filtration Rate Decline in Patients With Heart Failure. Journal of the American Heart Association 2024 11 13 (23): e036637. Dennis Pieper, Anja Sandek, Ann-Kathrin Schäfer, Hassan Dihazi, Gry Helene Dihazi, Andreas Leha, Michael Zeisberg, Stephan Lüders, Michael Koziolek, Manuel Wallba |
| Safety and Efficacy of Osimertinib in Patients With Non-Small-Cell Lung Cancer and Uncommon Tumoral Epidermal Growth Factor Receptor Mutations: A Systematic Review and Single-Arm Meta-Analysis. JCO precision oncology 2024 11 8 e2400331. Jonathan N Priantti, Yu Fujiwara, Francisco Cezar Aquino de Moraes, Isabella Michelon, Caio Castro, Natasha B Leighl, Ludimila Cavalcante, Alfredo Addeo, Jair Bar, Nobuyuki Horita, Alessio Cortellini, Amin H Nassar, Maysa Vilbert, Abdul Rafeh Naqa |
| Single nucleotide polymorphisms: impact on susceptibility to chemotherapy in patients with colorectal cancer. Future science OA 2024 11 10 (1): 2428077. M Angeles Vaz-Salgado, Victor Albarran, Javier Pozas, Reyes Ferreiro, Vanessa Pachón, Federico Longo, Mercedes Rodriguez, Emma Barreto, Julie Ea |
| Prognostic impact of PD-L1 expression in surgically resected EGFR-mutant lung adenocarcinoma: A real-world database study in Japan (CReGYT-01 EGFR study). International journal of cancer 2024 11 . Kotaro Nomura, Kazuki Takada, Fumihiko Kinoshita, Satoshi Muto, Taichi Matsubara, Yasunobu Kouki, Shinya Katsumata, Akira Hamada, Naoki Haratake, Kosuke Fujino, Mao Yoshikawa, Ken Suzawa, Kazuhiko Shien, Kenichi Suda, Shuta Ohara, Shota Fukuda, Hiroyuki Suzuki, Tatsuro Okamoto, Fumihiko Hirai, Keiju Aokage, Satoshi Shiono, Junichi Soh, Masahiro Tsuboi, Mototsugu Shimokawa, Yasuhisa Oh |
| Hearing loss phenotypes in Alport syndrome: experience in a tertiary referral center. Kidney research and clinical practice 2024 11 . Sang-Yoon Han, Myung-Whan Suh, Moo Kyun Park, Jun Ho Lee, Hee Gyung Kang, Sang-Yeon L |
| Kidney Outcomes in Transthyretin Amyloid Cardiomyopathy. JAMA cardiology 2024 11 . Adam Ioannou, Yousuf Razvi, Aldostefano Porcari, Muhammad U Rauf, Ana Martinez-Naharro, Lucia Venneri, Salsabeel Kazi, Ali Pasyar, Carina M Luxhøj, Aviva Petrie, William Moody, Richard P Steeds, Brett W Sperry, Ronald M Witteles, Carol Whelan, Ashutosh Wechalekar, Helen Lachmann, Philip N Hawkins, Scott D Solomon, Julian D Gillmore, Marianna Fonta |
| Plasma Alzheimer's disease biomarker variability: Amyloid-independent and amyloid-dependent factors. Alzheimer's & dementia : the journal of the Alzheimer's Association 2024 11 . Eun Hye Lee, Sung Hoon Kang, Daeun Shin, Young Ju Kim, Henrik Zetterberg, Kaj Blennow, Fernando Gonzalez-Ortiz, Nicholas J Ashton, Bo Kyoung Cheon, Heejin Yoo, Hongki Ham, Jihwan Yun, Jun Pyo Kim, Hee Jin Kim, Duk L Na, Hyemin Jang, Sang Won Seo, |
| Stage-specific efficacy of osimertinib in treatment-naïve EGFR-mutant non-small cell lung cancer according to baseline genetic alterations in circulating tumor DNA. Investigational new drugs 2025 1 . Yoshihiko Taniguchi, Akihiro Tamiya, Mitsuo Osuga, Shun-Ichi Isa, Keiichi Nakamura, Yasuyuki Mizumori, Tsutomu Shinohara, Hidetoshi Yanai, Katsumi Nakatomi, Masahide Oki, Masahide Mori, Tomohito Kuwako, Koji Yamazaki, Masahiro Shimada, Masahiko Ando, Yasuhiro K |
| Correlation between polymorphisms of SIRT2 gene and renal injury in patients with type 2 diabetes mellitus. Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences 2025 1 49 (7): 1005-1014. Su Wu, Bin Yi, Yali Dai, Xiangyu Liao, Juan Peng, Aimei |
| Abnormalities of IL-12 Family Cytokine Pathways in Autosomal Dominant Polycystic Kidney Disease Progression. Medicina (Kaunas, Lithuania) 2025 1 60 (12): . Corina-Daniela Ene, Ilinca Nicolae, Cristina C?pu |
| Comparative analysis of EGFR mutations in circulating tumor DNA and primary tumor tissues from lung cancer patients using BEAMing PCR. Scientific reports 2025 1 15 (1): 1252. Duhita Mirikar, Nandini Banerjee, Kumar Prabhash, Rajiv Kumar Kaushal, Vanita Naronha, C S Pramesh, George Karimundackal, Amit Joshi, Swapnil Rane, Ranjan Bas |
| Intrathecal pemetrexed improves survival outcomes in previously treated EGFR-mutant advanced non-small-cell lung cancer with leptomeningeal metastases. Heliyon 2025 1 10 (24): e40703. Liqun Li, Zhe Huang, Yangqian Chen, Hongzhi Ma, Xiaoquan Chen, Huan Yan, Haoyue Qin, Yuda Zhang, Xing Zhang, Wenjuan Jiang, Zhan Wang, Lin Zhang, Fanxu Zeng, Zhiguo Zhou, Xingxiang Pu, Nong Yang, Liang Zeng, Yongchang Zha |
| Brain radiotherapy combined with camrelizumab and platinum-doublet chemotherapy for previously untreated advanced non-small-cell lung cancer with brain metastases (C-Brain): a multicentre, single-arm, phase 2 trial. The Lancet. Oncology 2025 1 26 (1): 74-84. Yanjun Xu, Kaiyan Chen, Yujin Xu, Hui Li, Zhiyu Huang, Hongyang Lu, Dingzhi Huang, Sizhe Yu, Na Han, Lei Gong, Jing Qin, Jun Chen, Fajun Xie, Wei Hong, Xiao Lin, Fengzhuo Cheng, Xiaojie Luo, Yun F |
| Amivantamab Plus Lazertinib in Patients With EGFR-mutant Non-small Cell Lung Cancer (NSCLC) After Progression on Osimertinib and Platinum-based Chemotherapy: Results From CHRYSALIS-2 Cohort A. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2025 1 . Benjamin Besse, Koichi Goto, Yongsheng Wang, Se-Hoon Lee, Melina E Marmarelis, Yuichiro Ohe, Reyes Bernabe Caro, Dong-Wan Kim, Jong-Seok Lee, Sophie Cousin, Eiki Ichihara, Yongsheng Li, Luis Paz-Ares, Akira Ono, Rachel E Sanborn, Naohiro Watanabe, Maria Jose de Miguel, Carole Helissey, Catherine A Shu, Alexander I Spira, Pascale Tomasini, James Chih-Hsin Yang, Yiping Zhang, Enriqueta Felip, Frank Griesinger, Saiama N Waqar, Antonio Calles, Joel W Neal, Christina S Baik, Pasi A Jänne, S Martin Shreeve, Joshua C Curtin, Bharvin Patel, Michael Gormley, Xuesong Lyu, Jun Chen, Pei-Ling Chu, Janine Mahoney, Leonardo Trani, Joshua M Bauml, Meena Thayu, Roland E Knoblauch, Byoung Chul C |
| The relationship between kidney function and cardiometabolic risk factors, anthropometric indices, and dietary inflammatory index in the Iranian general population: a cross-sectional study. BMC nephrology 2025 1 26 (1): 5. Samaneh Madani, Seyed Jalil Masoumi, Afsane Ahmadi, Morteza Zare, Najmeh Hejazi, Sahar Fosha |
| Prognostic Analysis of Pathological Stage I Lung Adenocarcinoma Harboring Major EGFR Mutations. Clinical lung cancer 2025 1 . Shinkichi Takamori, Makoto Endo, Akira Hamada, Shuta Ohara, Shota Fukuda, Yasuaki Tomioka, Satoshi Takamori, Atsushi Osoegawa, Kotaro Nomura, Kosuke Fujino, Mao Yoshikawa, Ken Suzawa, Kazuhiko Shien, Kenichi Suda, Fumihiko Kinoshita, Kazuki Hayasaka, Hirotsugu Notsuda, Taichi Nagano, Kyoto Matsudo, Asato Hashinokuchi, Taichi Matsubara, Shinya Katsumata, Satoshi Shiono, Junichi Soh, Yasuhisa Ohde, Mototsugu Shimoka |
| Exon location of glycine substitutions impacts kidney survival in autosomal dominant Alport Syndrome. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2025 1 . Marie-Sophie Pagniez, Victor Fages, Clémence Gatinois, Romain Larrue, Nicolas Pottier, Timothée Laboux, Rémi Lenain, Olivier Grunewald, Thomas Robert, Claire Rigothier, Laurent Mesnard, François Glowac |
| Serum homocysteine and left ventricular hypertrophy in adults with chronic kidney disease: A case-control study. Medicine 2025 1 103 (47): e40577. Yanping Lei, Rui Liu, Yue Zh |
| RET-AREAL: a multi-center, real-world data analysis on the efficacy of pralsetinib in acquired RET fusion after resistance to EGFR/ALK-TKIs. Cancer letters 2025 1 217455. Xinjun Tang, Jie Hu, Renhua Guo, Yina Wang, Yu Yao, Liang Zeng, Haitao Wang, Haibo Shen, Jun Chen, Weina Huang, Lihua Liu, Ming Su, Zhuang Yu, Weidong Mao, Jinliang Wang, Haitao Tao, Guilan Dong, Chang Cai, Yupeng Xie, Tao Qu, Yan Zhang, Wei Shen, Jing Cao, Xin Cai, Wencui Kong, Xiaoxue Li, Fei Lia |
- Page last reviewed:Feb 1, 2024
- Content source: